AR077244A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE) - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE)

Info

Publication number
AR077244A1
AR077244A1 ARP100102272A ARP100102272A AR077244A1 AR 077244 A1 AR077244 A1 AR 077244A1 AR P100102272 A ARP100102272 A AR P100102272A AR P100102272 A ARP100102272 A AR P100102272A AR 077244 A1 AR077244 A1 AR 077244A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
hydroxipropane
dialil
alilamin
poli
Prior art date
Application number
ARP100102272A
Other languages
Spanish (es)
Inventor
Perez Sergio Lloret
Guasch Laura Diaz
Original Assignee
Combino Pharm Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combino Pharm Sl filed Critical Combino Pharm Sl
Priority to PCT/EP2010/059149 priority Critical patent/WO2010149794A2/en
Publication of AR077244A1 publication Critical patent/AR077244A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Una composicion farmacéutica solida para administracion oral que comprende de aproximadamente el 80% a aproximadamente el 94% en peso de sevelámero, incluyendo el agua de hidratacion, y al menos un excipiente farmacéuticamente aceptable.A solid pharmaceutical composition for oral administration comprising from about 80% to about 94% by weight of sevelamer, including hydration water, and at least one pharmaceutically acceptable excipient.

ARP100102272A 2009-06-26 2010-06-25 PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE) AR077244A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/059149 WO2010149794A2 (en) 2009-06-26 2010-06-28 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200930368A ES2350999B1 (en) 2009-06-26 2009-06-26 NEW PHARMACEUTICAL COMPOSITION UNDERSTANDING POLY HYDROCHLORIDE (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-PROPANE HYDROXY).
PCT/EP2009/058122 WO2010149230A1 (en) 2009-06-26 2009-06-29 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride

Publications (1)

Publication Number Publication Date
AR077244A1 true AR077244A1 (en) 2011-08-10

Family

ID=41728227

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102272A AR077244A1 (en) 2009-06-26 2010-06-25 PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE)

Country Status (4)

Country Link
AR (1) AR077244A1 (en)
CL (1) CL2012000375A1 (en)
ES (1) ES2350999B1 (en)
WO (1) WO2010149230A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108338975A (en) * 2017-01-25 2018-07-31 北京泰德制药股份有限公司 A kind of composition and preparation method thereof containing sevelamer or its pharmaceutical salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
IL149146A0 (en) * 1999-10-19 2002-11-10 Geltex Pharma Inc Direct compression polymer tablet core
US7749536B2 (en) * 2006-02-14 2010-07-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
BRPI0717008A2 (en) * 2006-09-01 2014-01-21 Usv Ltd PROCESS FOR PREPARING SEVELAMER CHLORIDE AND FORMULATING IT
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer

Also Published As

Publication number Publication date
ES2350999B1 (en) 2011-12-07
WO2010149230A1 (en) 2010-12-29
ES2350999A1 (en) 2011-01-28
CL2012000375A1 (en) 2012-07-27

Similar Documents

Publication Publication Date Title
AR115939A2 (en) COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE
CR20110435A (en) FORMULATIONS OF 4-AMINO-2- (2,6-DIOXOPIPERIDINA-3-IL) ISOINDOLINA-1,3-DIONA
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
AR089578A1 (en) COMPOSITIONS, METHODS TO TREAT HEPATITIS C VIRUS AND PREPARATION PROCESS
UY32490A (en) BETA-SECRETASA INHIBITORS
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
ES2916604T1 (en) Nrf2 Detection Assays and Related Methods and Compositions
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
GT201200126A (en) CHROMENONE DERIVATIVES WITH ANTI-TUMORAL ACTIVITY
CO6470847A2 (en) AMINO-PROPIONIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
ECSP11011561A (en) AMINOBUTYRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
MA32812B1 (en) Pharmaceutical composition of a powerful antagonist for oral VHC
PE20120713A1 (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS FOR ITS USE
ECSP12011958A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SIGMA RECEIVER LEAGUES
ECSP13012812A (en) IMMUNOSUPPRESSOR FORMULATIONS
EA201071039A1 (en) NEW DERIVATIVES 1-BENZYL-3-HYDROXYMETYLINDASOL AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 And P40
TN2015000135A1 (en) Modified release formulations for oprozomib
AR077284A1 (en) SOLID PHARMACEUTICAL FIXED DOSAGE COMPOSITIONS INCLUDING IRBESARTAN AND AMLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
CO6351721A2 (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF ICTUS OR TRANSITIONAL ISCHEMICAL ATTACK
CR11734A (en) USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
BR112012013199A2 (en) compound, pharmaceutical composition, and use of a compound
AR080256A1 (en) SOLID PHARMACEUTICAL FORMULATIONS OF RAMIPRIL AND AMLODIPINO BESYLATE AND ITS PREPARATION
AR077244A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES POLI (ALILAMIN-CO-N, N'-DIALIL-1,3-DIAMINO-2-HYDROXIPROPANE)
CO6331429A2 (en) DERIVATIVES OF 5- (4-METHANOSULPHONYL-PHENYL) -TIAZOL FOR THE TREATMENT OF ACUTE AND CHRONIC INFLAMMATORY DISEASES
WO2010149794A3 (en) Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)

Legal Events

Date Code Title Description
FB Suspension of granting procedure